Gluten sensitivity affects about 10% of the global population, with higher rates in women and some countries like the UK and Saudi Arabia. Many self-report symptoms without clear biomarkers linking them to gluten. FODMAPs may play a significant role, leading to questions about the gluten-free market’s future amidst these findings.












